Answers are grounded in this paper and cite their sources.
The authors show that cinacalcet, which mediates allosteric modulation of the calcium-sensing receptor, corrects loss of function of AP2S1 mutations that cause familial hypocalciuric hypercalcemia type 3 and ameliorates symptomatic hypercalcemia.
No takes yet. Share an insight, caveat, or question.
Howles et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: